Literature DB >> 16629786

Attenuation of human lung mast cell degranulation by bronchial epithelium.

W Yang1, A J Wardlaw, P Bradding.   

Abstract

BACKGROUND: Human lung mast cells (HLMC) lie in close proximity to the bronchial epithelium in asthma and adhere with high affinity to bronchial epithelial monolayers in vitro. We investigated the consequences of this adhesive interaction on HLMC activation in response to Fc epsilon RI cross-linking.
METHODS: Human lung mast cells were cultured with the bronchial epithelial cell line BEAS-2B or plastic control for either 30 min or 16 h and then activated with anti-IgE. Histamine was measured by radioenzymatic assay.
RESULTS: After co-culture for 30 min, IgE-dependent histamine release from HLMC was identical on both BEAS-2B and plastic. After 16 h of co-culture, there was a marked decrease in constitutive and IgE-dependent histamine release from HLMC cultured on BEAS-2B compared with those cultured on plastic or fibronectin. In contrast, the Ca(2+)/ATPase inhibitor thapsigargin produced concentration-dependent histamine release that was significantly increased on BEAS-2B compared with plastic. IgE-dependent degranulation was not significantly affected by BEAS-2B-conditioned medium.
CONCLUSIONS: BEAS-2B bronchial epithelial cells attenuate IgE-dependent but not thapsigargin-induced histamine release from HLMC. The differential effect with anti-IgE compared with thapsigargin suggests that the mechanism includes interference with the proximal Fc epsilon RI signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629786     DOI: 10.1111/j.1398-9995.2006.01041.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.

Authors:  J M Brown; K Nemeth; N M Kushnir-Sukhov; D D Metcalfe; E Mezey
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

Review 2.  Mast cells in airway diseases and interstitial lung disease.

Authors:  Glenn Cruse; Peter Bradding
Journal:  Eur J Pharmacol       Date:  2015-05-08       Impact factor: 4.432

3.  Asthma: eosinophil disease, mast cell disease, or both?

Authors:  Peter Bradding
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

4.  Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6.

Authors:  Fay Hollins; Davinder Kaur; Weidong Yang; Glenn Cruse; Ruth Saunders; Amanda Sutcliffe; Patrick Berger; Akihiko Ito; Christopher E Brightling; Peter Bradding
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

5.  Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation.

Authors:  Neil Martin; Andrew Ruddick; Greer K Arthur; Heidi Wan; Lucy Woodman; Christopher E Brightling; Don J L Jones; Ian D Pavord; Peter Bradding
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

Review 6.  Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases.

Authors:  Philipp M Hagemann; Stephanie Nsiah-Dosu; Jennifer Elisabeth Hundt; Karin Hartmann; Zane Orinska
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

7.  Novel airway smooth muscle-mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma.

Authors:  Sara J Bonvini; Mark A Birrell; Eric Dubuis; John J Adcock; Michael A Wortley; Pauline Flajolet; Peter Bradding; Maria G Belvisi
Journal:  Eur Respir J       Date:  2020-07-02       Impact factor: 16.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.